EVENTS
Pathological Specimens and Data - What controls should be in place?
- April 23, 2002
- Dinner, Discussion
|
Dr Robert Coleman Chief Scientific Officer, Pharmagene Laboratories Ltd |
|
Steve Catling Chief Executive, The Retained Organs Commission |
|
Professor Nick Wright FMedSci Warden, Barts Hospital and The London School of Medicine and Dentistry |
Cancer Research UK, Department of Health, Medical Research Council, The Wellcome Trust
This discussion appeared in the FST journal below.